Baudax Bio Inc (BXRX)

NASDAQ
0.7400
-0.0025(-0.34%)
  • Volume:
    88,330
  • Day's Range:
    0.7000 - 0.7516
  • 52 wk Range:
    0.7000 - 32.7215

BXRX Overview

Prev. Close
0.7497
Day's Range
0.7-0.7516
Revenue
1.3M
Open
0.7
52 wk Range
0.7-32.7215
EPS
-6.19
Volume
88,330
Market Cap
5.97M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
382,684
P/E Ratio
-
Beta
-
1-Year Change
-97.45%
Shares Outstanding
8,068,853
Next Earnings Date
14 Aug 2022
What is your sentiment on Baudax Bio?
or
Vote to see community's results!

Baudax Bio Inc News

Baudax Bio Inc Company Profile

Baudax Bio Inc Company Profile

Employees
80

Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care settings. The company offers ANJESO (meloxicam) injection for the management of moderate to severe pain, alone or in combination with non-NSAID analgesics. Its products under development includes BX1000, an intermediate-acting neuromuscular blocking agent (NMB) that is in phase II clinical trial; BX2000, an ultra- short acting NMBA, which is in phase I clinical trial; BX3000, an NMBA reversal agent; and Dex-IN, a proprietary intranasal formulation of dexmedetomidine. The company was incorporated in 2019 and is based in Malvern, Pennsylvania.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsSellStrong SellBuyStrong SellStrong Sell
SummaryStrong SellStrong SellNeutralStrong SellStrong Sell
  • target $4
    0